A carregar...

DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

The recently approved drugs 5-azacitidine and 5-aza-2′-deoxyazacytidine are in wide clinical use for the treatment of myelodysplastic syndrome of all types and chronic myelomonocytic leukemia. These agents were developed based upon an understanding of the importance of epigenetic changes in malignan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Griffiths, Elizabeth A., Gore, Steven D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2234265/
https://ncbi.nlm.nih.gov/pubmed/18179966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2007.11.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!